Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-(3,4-dihydroxyphenyl)ethyl (2s-(2alpha,3e,4beta))-3-ethylidene-2-(beta-d-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2h-pyran-4-acetate
2. Oleoeuropein
3. Oleoeuropeine
1. 32619-42-4
2. Oleoeuropein
3. Oleoeuropeine
4. 2-(3,4-dihydroxyphenyl)ethyl (2s-(2alpha,3e,4beta))-3-ethylidene-2-(beta-d-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2h-pyran-4-acetate
5. Methyl (4s,5e,6s)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-ethylidene-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4h-pyran-3-carboxylate
6. 2o4553545l
7. 2h-pyran-4-acetic Acid, 3-ethylidene-2-(.beta.-d-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-, 2-(3,4-dihydroxyphenyl)ethyl Ester, (2s,3e,4s)-
8. Methyl (2s,3e,4s)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-pyran-5-carboxylate
9. Einecs 251-129-6
10. Oleuroperin
11. Unii-2o4553545l
12. Oleuropein [mi]
13. Oleuropein [inci]
14. Oleuropein [vandf]
15. Oleuropein, >=98.0%
16. Oleuropein [usp-rs]
17. Oleuropein [who-dd]
18. Oleuropein, Analytical Standard
19. Chebi:7747
20. Megxp0_000369
21. Schembl4306969
22. Chembl1911053
23. Oleuropein, >=80% (hplc)
24. Acon1_000443
25. Gtpl11027
26. Dtxsid60905103
27. Hy-n0292
28. Zinc4098348
29. Mfcd16879008
30. Akos015900702
31. Ccg-269961
32. Ncgc00169074-01
33. Ncgc00169074-02
34. As-56230
35. Cs-0008800
36. O0420
37. S7867
38. A12095
39. Q402625
40. Oleuropein, Primary Pharmaceutical Reference Standard
41. Brd-k08037284-001-01-4
42. Oleuropein, European Pharmacopoeia (ep) Reference Standard
43. Oleuropein, United States Pharmacopeia (usp) Reference Standard
44. (4s)-5,6-dihydro-5-ethylidene-3-(methoxycarbonyl)-6alpha-(beta-d-glucopyranosyloxy)-4h-pyran-4beta-acetic Acid 2-(3,4-dihydroxyphenyl)ethyl Ester
45. [2s-(2alpha,3e,4beta)]-3-ethylidene-2-(beta-d-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2h-pyran-4-acetic Acid 2-(3,4-dihydroxyphenyl)ethyl Ester
46. 2h-pyran-4-acetic Acid, 3-ethylidene-2-(.beta.-d-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-, 2-(3,4-dihydroxyphenyl)ethyl Ester, (2s-(2.alpha.,3e,4.beta.))-
47. 2h-pyran-4-acetic Acid, 5-carboxy-3-ethylidene-2-(.beta.-d-glucosyloxy)-3,4-dihydro-, 3,4-dihydroxyphenethyl 5-methyl Ester
48. Methyl (2s,3e,4s)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(beta-d-glucopyranosyloxy)-3,4-dihydro-2h-pyran-5-carboxylate
49. Methyl (2s,4s,e)-4-(2-(3,4-dihydroxyphenethoxy)-2-oxoethyl)-3-ethylidene-2-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-3,4-dihydro-2h-pyran-5-carboxylate
50. Methyl (4s,5e,6s)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxo-ethyl]-5-ethylidene-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4h-pyran-3-carboxylate
| Molecular Weight | 540.5 g/mol |
|---|---|
| Molecular Formula | C25H32O13 |
| XLogP3 | -0.4 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 11 |
| Exact Mass | 540.18429107 g/mol |
| Monoisotopic Mass | 540.18429107 g/mol |
| Topological Polar Surface Area | 202 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 873 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
57
PharmaCompass offers a list of Oleuropein API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oleuropein manufacturer or Oleuropein supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oleuropein manufacturer or Oleuropein supplier.
PharmaCompass also assists you with knowing the Oleuropein API Price utilized in the formulation of products. Oleuropein API Price is not always fixed or binding as the Oleuropein Price is obtained through a variety of data sources. The Oleuropein Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oleuropein manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oleuropein, including repackagers and relabelers. The FDA regulates Oleuropein manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oleuropein API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Oleuropein supplier is an individual or a company that provides Oleuropein active pharmaceutical ingredient (API) or Oleuropein finished formulations upon request. The Oleuropein suppliers may include Oleuropein API manufacturers, exporters, distributors and traders.
Oleuropein Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oleuropein GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oleuropein GMP manufacturer or Oleuropein GMP API supplier for your needs.
A Oleuropein CoA (Certificate of Analysis) is a formal document that attests to Oleuropein's compliance with Oleuropein specifications and serves as a tool for batch-level quality control.
Oleuropein CoA mostly includes findings from lab analyses of a specific batch. For each Oleuropein CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oleuropein may be tested according to a variety of international standards, such as European Pharmacopoeia (Oleuropein EP), Oleuropein JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oleuropein USP).
